Search

Your search keyword '"Deloose, Koen"' showing total 16 results
Start Over Author "Deloose, Koen" Publisher edizioni minerva medica
16 results on '"Deloose, Koen"'

1. ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis

Author

BOSIERS, Marc, primary, DE DONATO, Gianmarco, additional, TORSELLO, Giovanni, additional, GALVAGNI SILVEIRA, Pierre, additional, DELOOSE, Koen, additional, SCHEINERT, Dierk, additional, VEROUX, Pierfrancesco, additional, HENDRIKS, Jeroen, additional, MAENE, Lieven, additional, KEIRSE, Koen, additional, NAVARRO, Tulio, additional, CALLAERT, Joren, additional, ECKSTEIN, Hans-Henning, additional, TEΒAREK, Jörg, additional, GIAQUINTA, Alessia, additional, van den EYNDE, Wouter, additional, VERBIST, Jürgen, additional, and AHL-GRAVSEN, Jasmin, additional

Published
2023
Full Text
View/download PDF

2. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial

Author

Bosiers, Marc, primary, Deloose, Koen, additional, Callaert, Joren, additional, Verbist, Jürgen, additional, Hendriks, Jeroen, additional, Lauwers, Patrick, additional, Schroë, Herman, additional, Lansink, Wouter, additional, Scheinert, Dierk, additional, Schmidt, Andrej, additional, Zeller, Thomas, additional, Beschorner, Ulrich, additional, Noory, Elias, additional, Torsello, Giovanni, additional, Austermann, Martin, additional, and Wauters, Jeroen, additional

Published
2020
Full Text
View/download PDF

3. One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions

Author

Bosiers, Marc, primary, Deloose, Koen, additional, Torsello, Giovanni, additional, Scheinert, Dierk, additional, Verbist, Jürgen, additional, van den Eynde, Wouter, additional, Maene, Lieven, additional, Beelen, Roel, additional, Keirse, Koen, additional, Hendriks, Jeroen, additional, Callaert, Joren, additional, Bosiers, Michel, additional, and Wauters, Jeroen, additional

Published
2020
Full Text
View/download PDF

6. EVOLUTION Study: 12-month results

Author

Bosiers, Marc, primary, Deloose, Koen, additional, Callaert, Joren, additional, Peeters, Patrick, additional, Verbist, Jürgen, additional, van den Eynde, Wouter, additional, Maene, Lieven, additional, Beelen, Roel, additional, Keirse, Koen, additional, and Wauters, Jeroen, additional

Published
2019
Full Text
View/download PDF

7. BeGraft Peripheral PMCF Study: 12-month results

Author

Deloose, Koen, primary, Bosiers, Marc, additional, Callaert, Joren, additional, Peeters, Patrick, additional, Verbist, Jurgen, additional, van den Eynde, Wouter, additional, Maene, Lieven, additional, Beelen, Roel, additional, and Keirse, Koen, additional

Published
2019
Full Text
View/download PDF

11. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial

Author

Nasser, Felipe, primary, Kambara, Antonio, additional, Abath, Carlos, additional, Cavalcanti, Douglas, additional, Barros, Ilana, additional, Pires, Norma, additional, Rivera, Marco, additional, Neser, Adnan, additional, Ingrund, Jose, additional, Burihan, Marcelo, additional, Silveira, Pierre, additional, Galego, Gilberto, additional, Bortoluzzi, Cristiano, additional, Franklin, Rafael, additional, Bosiers, Marc, additional, Deloose, Koen, additional, Razuk, Alvaro, additional, Caffaro, Roberto, additional, Karakhanian, Walter K., additional, Park, Jong, additional, Lopes, Caetano, additional, Pinto, Daniel, additional, Bez, Leonardo, additional, Lopes, Rodrigo, additional, Mourão, André, additional, and Kleinsorge, Gustavo, additional

Published
2017
Full Text
View/download PDF

14. Comparative analysis of carotid artery stenting practice and outcomes across operator specialties: insights from a prespecified subanalysis of a large real-world patient cohort (ROADSAVER Study).

Author

Schwindt A, Kedev S, Vajda Z, Deloose K, Latacz P, Cvetic V, Müller-Hülsbeck S, and Langhoff R

Subjects
Humans, Aged, Male, Female, Treatment Outcome, Europe, Time Factors, Risk Factors, Carotid Stenosis therapy, Carotid Stenosis mortality, Carotid Stenosis surgery, Surgeons, Practice Patterns, Physicians', Cardiologists, Aged, 80 and over, Healthcare Disparities, Specialization, Clinical Competence, Middle Aged, Risk Assessment, Stents, Endovascular Procedures adverse effects, Endovascular Procedures instrumentation, Endovascular Procedures mortality, Stroke etiology, Stroke epidemiology, Radiologists
Abstract

Background: In contemporary clinical practice, carotid artery stenting (CAS) is increasingly becoming a multispecialty field, joining operators of various training backgrounds, which bring forth their unique expertise, patient management philosophies, and procedural preferences. The best practices and approaches, however, are still debated. Therefore, real-world insights on different operator preferences and related outcomes are of utmost value, yet still rather scarce in the available literature., Methods: Using the data collected in the ROADSAVER observational, European multicenter CAS study, a prespecified comparative analysis evaluating the impact of the operator's specialization was performed. We used major adverse event (MAE) rate at 30-day follow-up, defined as the cumulative incidence of any death or stroke, and its components as outcome measures., Results: A total of 1965 procedures were analyzed; almost half 878 (44.7%) were performed by radiologists (interventional/neuro), 717 (36.5%) by cardiologists or angiologists, and 370 (18.8%) by surgeons (vascular/neuro). Patients treated by surgeons were the oldest (72.9±8.5), while radiologists treated most symptomatic patients (58.1%) and more often used radial access (37.2%). The 30-day MAE incidence achieved by cardiologists/angiologists was 2.0%, radiologists 2.5%, and surgeons 1.9%; the observed differences in rates were statistically not-significant (P=0.7027), even when adjusted for baseline patient/lesion and procedural disparities across groups. The corresponding incidence rates for death from any cause were 1.0%, 0.8%, and 0.3%, P=0.4880, and for any stroke: 1.4%, 2.3%, and 1.9%, P=0.4477, respectively., Conclusions: Despite the disparities in patient selection and procedural preferences, the outcomes achieved by different specialties in real-world, contemporary CAS practice remain similar when using modern devices and techniques.

Published
2024
Full Text
View/download PDF

15. Drug-eluting stents in superficial femoral artery treatment: could they be the standard of care?

Author

Bosiers M, Deloose K, Callaert J, Peeters P, and Bosiers M

Subjects
Constriction, Pathologic, Endovascular Procedures adverse effects, Humans, Peripheral Arterial Disease diagnostic imaging, Peripheral Arterial Disease physiopathology, Prosthesis Design, Risk Factors, Treatment Outcome, Vascular Access Devices standards, Vascular Patency, Cardiovascular Agents administration & dosage, Coated Materials, Biocompatible standards, Drug-Eluting Stents standards, Endovascular Procedures instrumentation, Endovascular Procedures standards, Femoral Artery diagnostic imaging, Femoral Artery physiopathology, Peripheral Arterial Disease therapy, Standard of Care
Abstract

Endovascular techniques have improved markedly over the past several decades. Plain old balloon angioplasty can only reach patencies around 40% after 1 year. Scaffolding stents have resulted in improved short-term results but encountered limitations for longer-term durability. With the introduction of drug-eluting technologies the process of intimal hyperplasia might be slowed, resulting in improved long-term patency results. At first, limus-eluting technologies were not able to transfer the enthusiasm from the coronaries to the infrainguinal vascular bed. However, the newer generation paclitaxel-eluting technologies perform significantly better in femoropopliteal arteries than their non-eluting or non-coated counterparts. The results of a prospective randomized trial comparing DES versus DCB is eagerly awaited. For the moment there seems, based on the meta-analysis, no difference between the two treatment modalities. Although, we need to keep in mind that DCB perform worse in long calcified lesions.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results